Additional file 4: Figure S2. of Cancer network activity associated with therapeutic response and synergism
- Jordi Serra-Musach (196533)
- Francesca Mateo (716101)
- Eva Capdevila-Busquets (683895)
- Gorka de Garibay (3438329)
- Xiaohu Zhang (391063)
- Raj Guha (3438323)
- Craig Thomas (288536)
- Judit Grueso (646003)
- Alberto Villanueva (196524)
- Samira Jaeger (74247)
- Holger Heyn (126177)
- Miguel Vizoso (3292488)
- Hector Pérez (3438338)
- Alex Cordero (3438335)
- Eva Gonzalez-Suarez (3438320)
- Manel Esteller (74345)
- Gema Moreno-Bueno (210931)
- Andreas Tjärnberg (3438332)
- Conxi Lázaro (142579)
- Violeta Serra (3097938)
- Joaquín Arribas (754747)
- Mikael Benson (159069)
- Mika Gustafsson (159059)
- Marc Ferrer (191300)
- Patrick Aloy (5666)
- Miquel Pujana (3438326)
View in ORKG Publication date
August 2016
DOIAbstract
Corroboration of CNA-IC50 correlations using a high-quality interactome dataset. The PCC distribution difference between drugs that target CTKs or STKs is maintained when the network is based on a high-quality dataset derived from the combination of reliable literature-curated binary interactions and well-verified high-throughput yeast two-hybrid interactions. (PDF 162 kb